Skip to main content

Advertisement

Log in

Retinopathy screening in patients with Type 1 diabetes diagnosed in young age using a non-mydriatic digital stereoscopic retinal imaging

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Diabetic retinopathy seriously impairs patients’ quality of life, since it represents the first cause of blindness in industrialized countries. Aim: To estimate prevalence of retinopathy in young Type 1 diabetes patients using a non-mydriatic digital stereoscopic retinal imaging (NMDSRI), and to evaluate the impact of socio-demographic, clinical, and metabolic variables. Subjects and methods: In 247 young patients glycated hemoglobin (HbA1c), gender, age, pubertal stage, presence of diabetic ketoacidosis (DKA), HLA-DQ heterodimers of susceptibility for Type 1 diabetes, and β-cell autoimmunity at clinical onset were considered. At retinopathy screening, we evaluated age, disease duration, pubertal stage, body mass index (BMI-SDS), insulin requirement, HbA1c levels, other autoimmune diseases, diabetes-related complications, serum concentrations of cholesterol and triglycerides, systolic and diastolic blood pressure. Results: Retinopathy was found in 26/247patients: 25 showed background retinopathy, and 1 had a sight-threatening retinopathy. A significant relationship between retinopathy and female gender (p=0.01), duration of disease ≥15 yr (p<0.0001), serum triglycerides levels >65 mg/dl (p=0.012) and mean HbA1c ≥7.5% or >9% (p=0.0014) were found at the multivariate logistic analysis. Conclusions: Metabolic control is the most important modifiable factor and promotion of continuous educational process to reach a good metabolic control is a cornerstone to prevent microangiopathic complications. Symptoms appear when the complication is already established; a screening program with an early diagnosis is mandatory to prevent an irreversible damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURO-DIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 2009, 373: 2027–33.

    Article  PubMed  Google Scholar 

  2. Fong DS, Aiello L, Gardner TW, et al. American Diabetes Association. Retinopathy in diabetes. Diabetes Care 2004, 27(Suppl 1): S84–7.

    Article  PubMed  Google Scholar 

  3. Alibrahim E, Donaghue KC, Rogers S, et al. Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology 2006, 113: 1499–500.

    Article  PubMed  Google Scholar 

  4. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006–2007. Microvascular and macrovascular complications. Pediatr Diab 2007, 8: 163–70.

    Article  Google Scholar 

  5. Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001, 24: 1275–9.

    Article  CAS  PubMed  Google Scholar 

  6. Morello CM. Etiology and natural history of diabetic retinopathy: an overview. Am J Health Syst Pharm 2007, 64 (17 Suppl): S3–7.

    Article  PubMed  Google Scholar 

  7. Sano H, Nishimura R, Asao K, et al; Diabetes Epidemiology Research International Study Group. Blindness and laser photocoagulation in patients with childhood-onset type 1 diabetes in Japan. Br J Ophthalmol 2009, 93: 726–30.

    Article  CAS  PubMed  Google Scholar 

  8. Silverstein J, Klingensmith G, Copeland K, et al; American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005, 28: 186–212.

    Article  PubMed  Google Scholar 

  9. Huo B, Steffen AT, Swan K, Sikes K, Weinzimer SA, Tamborlane WV. Clinical outcomes and cost-effectiveness of retinopathy screening in youth with type 1 diabetes. Diabetes Care 2007, 30: 362–3.

    Article  PubMed  Google Scholar 

  10. Maguire A, Chan A, Cusumano J, et al. The case for biennial retinopathy screening in children and adolescents. Diabetes Care 2005, 28: 509–13.

    Article  PubMed  Google Scholar 

  11. Ahmed J, Ward TP, Bursell SE, Aiello LM, Cavallerano JD, Vigersky RA. The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy. Diabetes Care 2006, 29: 2205–9.

    Article  PubMed  Google Scholar 

  12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl 1): S62–7.

    Article  PubMed Central  Google Scholar 

  13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114 (2 Suppl 4th Report): 555–76.

    Article  Google Scholar 

  14. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990, 44: 45–60.

    CAS  PubMed  Google Scholar 

  15. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007, 85: 660–7.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Harvey JN, Allagoa B. The long-term renal and retinal outcome of childhood onset type1 diabetes. Diabet Med 2003, 21: 26–31.

    Article  Google Scholar 

  17. Svensson M, Eriksson JW, Dahlquist G. Early glycemic control, age at onset and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care 2004, 27: 955–62.

    Article  PubMed  Google Scholar 

  18. Monti MC, Lonsdale JT, Montomoli C, Montross R, Schlag E, Greenberg DA. Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes. J Clin Endocrinol Metab 2007, 92: 4650–5.

    Article  CAS  PubMed  Google Scholar 

  19. Goldstein DE, Blinder KJ, Ide CH, et al. Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal study. Ophthalmology 1993, 100: 1125–31.

    Article  CAS  PubMed  Google Scholar 

  20. d’Annunzio G, Malvezzi F, Vitali L, et al. A 3–19-year follow-up study on diabetic retinopathy in patients diagnosed in childhood and treated with conventional therapy. Diabet Med 1997, 14: 951–8.

    Article  PubMed  Google Scholar 

  21. Skrivarhaug T, Fosmark DS, Stene LC, et al. Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study. Diabetologia 2006, 49: 2281–90.

    Article  CAS  PubMed  Google Scholar 

  22. Massin P, Erginay A, Mercat-Caudal I, et al. Prevalence of diabetic retinopathy in children and adolescents with type-1 diabetes attending summer camps in France. Diabet Metab 2007, 33: 284–9.

    Article  CAS  Google Scholar 

  23. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329: 977–86.

    Article  Google Scholar 

  24. Franklin VL, Khan F, Kennedy G, Belch JJ, Greene SA. Intensive insulin therapy improves endothelial function and microvascular reactivity in young people with type 1 diabetes. Diabetologia 2008, 51: 353–60.

    Article  CAS  PubMed  Google Scholar 

  25. Lopez-Bastida J, Cabrera-Lopez F, Serrano-Aguilar P. Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy. Diabet Med 2007, 24: 403–7.

    Article  CAS  PubMed  Google Scholar 

  26. White NH, Sun W, Cleary PA, et al; DCCT-EDIC Research Group. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes 2010, 59: 1244–53.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009, 116: 497–503.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN; DCCT/EDIC Research Group. The Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial — Revisited. Diabetes 2008, 57: 995–1001.

    Article  CAS  PubMed  Google Scholar 

  29. Porta M, Sjoelie AK, Chaturvedi N, et al; EURODIAB Prospective Complications Study Group. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 2001, 44: 2203–9.

    Article  CAS  PubMed  Google Scholar 

  30. Gallego PH, Craig ME, Hing S, Donaghue KC. Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study. BMJ 2008, 337: a918.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Hietala K, Harjutsalo V, Forsblom C, Summanen P, Groop PH; FinnDiane Study Group. Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care 2010, 33: 1315–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Amin R, Widmer B, Prevost AT, et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 2008, 336: 697–701.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Olsen BS, Johannesen J, Sjølie AK, et al. Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med 1999, 16: 79–85.

    Article  CAS  PubMed  Google Scholar 

  34. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA 2007, 298: 902–16.

    Article  CAS  PubMed  Google Scholar 

  35. Gallego PH, Wiltshire E, Donaghue KC. Identifying children at particular risk of long-term diabetes complications. Pediatr Diab 2007, 8: 40–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. d’Annunzio MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minuto, N., Emmanuele, V., Vannati, M. et al. Retinopathy screening in patients with Type 1 diabetes diagnosed in young age using a non-mydriatic digital stereoscopic retinal imaging. J Endocrinol Invest 35, 389–394 (2012). https://doi.org/10.3275/8016

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/8016

Key-words

Navigation